Literature DB >> 22056715

Classification of scaffold-hopping approaches.

Hongmao Sun1, Gregory Tawa, Anders Wallqvist.   

Abstract

The general goal of drug discovery is to identify novel compounds that are active against a preselected biological target with acceptable pharmacological properties defined by marketed drugs. Scaffold hopping has been widely applied by medicinal chemists to discover equipotent compounds with novel backbones that have improved properties. In this article we classify scaffold hopping into four major categories, namely heterocycle replacements, ring opening or closure, peptidomimetics and topology-based hopping. We review the structural diversity of original and final scaffolds with respect to each category. We discuss the advantages and limitations of small, medium and large-step scaffold hopping. Finally, we summarize software that is frequently used to facilitate different kinds of scaffold-hopping methods.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22056715      PMCID: PMC3328312          DOI: 10.1016/j.drudis.2011.10.024

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  113 in total

Review 1.  Cox-2-selective inhibitors: the new super aspirins.

Authors:  D L DeWitt
Journal:  Mol Pharmacol       Date:  1999-04       Impact factor: 4.436

2.  Characteristic physical properties and structural fragments of marketed oral drugs.

Authors:  Michal Vieth; Miles G Siegel; Richard E Higgs; Ian A Watson; Daniel H Robertson; Kenneth A Savin; Gregory L Durst; Philip A Hipskind
Journal:  J Med Chem       Date:  2004-01-01       Impact factor: 7.446

3.  Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium- 3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)- 2-[4-cyclohexyl-4-(1H-1,2,4-triazol- 1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist.

Authors:  Iyassu K Sebhat; William J Martin; Zhixiong Ye; Khaled Barakat; Ralph T Mosley; David B R Johnston; Raman Bakshi; Brenda Palucki; David H Weinberg; Tanya MacNeil; Rubana N Kalyani; Rui Tang; Ralph A Stearns; Randy R Miller; Constantin Tamvakopoulos; Alison M Strack; Erin McGowan; Doreen E Cashen; Jennifer E Drisko; Gary J Hom; Andrew D Howard; D Euan MacIntyre; Lex H T van der Ploeg; Arthur A Patchett; Ravi P Nargund
Journal:  J Med Chem       Date:  2002-10-10       Impact factor: 7.446

4.  "Lead hopping". Validation of topomer similarity as a superior predictor of similar biological activities.

Authors:  Richard D Cramer; Robert J Jilek; Stefan Guessregen; Stephanie J Clark; Bernd Wendt; Robert D Clark
Journal:  J Med Chem       Date:  2004-12-30       Impact factor: 7.446

5.  SHOP: scaffold HOPping by GRID-based similarity searches.

Authors:  Rikke Bergmann; Anna Linusson; Ismael Zamora
Journal:  J Med Chem       Date:  2007-05-10       Impact factor: 7.446

6.  PubChem as a source of polypharmacology.

Authors:  Bin Chen; David Wild; Rajarshi Guha
Journal:  J Chem Inf Model       Date:  2009-09       Impact factor: 4.956

Review 7.  Peptidomimetics, a synthetic tool of drug discovery.

Authors:  Josef Vagner; Hongchang Qu; Victor J Hruby
Journal:  Curr Opin Chem Biol       Date:  2008-05-14       Impact factor: 8.822

8.  Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.

Authors:  Domagoj Vucic; Matthew C Franklin; Heidi J A Wallweber; Kanad Das; Brendan P Eckelman; Hwain Shin; Linda O Elliott; Saloumeh Kadkhodayan; Kurt Deshayes; Guy S Salvesen; Wayne J Fairbrother
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

9.  A selective AT2 receptor ligand with a gamma-turn-like mimetic replacing the amino acid residues 4-5 of angiotensin II.

Authors:  Ulrika Rosenström; Christian Sköld; Gunnar Lindeberg; Milad Botros; Fred Nyberg; Anders Karlén; Anders Hallberg
Journal:  J Med Chem       Date:  2004-02-12       Impact factor: 7.446

10.  An overview of the PubChem BioAssay resource.

Authors:  Yanli Wang; Evan Bolton; Svetlana Dracheva; Karen Karapetyan; Benjamin A Shoemaker; Tugba O Suzek; Jiyao Wang; Jewen Xiao; Jian Zhang; Stephen H Bryant
Journal:  Nucleic Acids Res       Date:  2009-11-19       Impact factor: 16.971

View more
  52 in total

Review 1.  Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.

Authors:  Zhiyan Xiao; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2015-09-11       Impact factor: 12.944

2.  A structural biology approach enables the development of antimicrobials targeting bacterial immunophilins.

Authors:  Darren W Begley; David Fox; Dominic Jenner; Christina Juli; Phillip G Pierce; Jan Abendroth; Muigai Muruthi; Kris Safford; Vanessa Anderson; Kateri Atkins; Steve R Barnes; Spencer O Moen; Amy C Raymond; Robin Stacy; Peter J Myler; Bart L Staker; Nicholas J Harmer; Isobel H Norville; Ulrike Holzgrabe; Mitali Sarkar-Tyson; Thomas E Edwards; Donald D Lorimer
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

3.  Computational studies to predict or explain G protein coupled receptor polypharmacology.

Authors:  Kenneth A Jacobson; Stefano Costanzi; Silvia Paoletta
Journal:  Trends Pharmacol Sci       Date:  2014-11-14       Impact factor: 14.819

Review 4.  Scaffold-hopping as a strategy to address metabolic liabilities of aromatic compounds.

Authors:  Phillip R Lazzara; Terry W Moore
Journal:  RSC Med Chem       Date:  2019-12-16

5.  Predicting protein-ligand affinity with a random matrix framework.

Authors:  Alpha A Lee; Michael P Brenner; Lucy J Colwell
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-16       Impact factor: 11.205

6.  Minimizing the Contribution of Enterohepatic Recirculation to Clearance in Rat for the NCINI Class of Inhibitors of HIV.

Authors:  Lee D Fader; Rebekah Carson; Sébastien Morin; François Bilodeau; Catherine Chabot; Ted Halmos; Murray D Bailey; Stephen H Kawai; René Coulombe; Steven Laplante; Kevork Mekhssian; Araz Jakalian; Michel Garneau; Jianmin Duan; Stephen W Mason; Bruno Simoneau; Craig Fenwick; Youla Tsantrizos; Christiane Yoakim
Journal:  ACS Med Chem Lett       Date:  2014-04-16       Impact factor: 4.345

Review 7.  Computational functional group mapping for drug discovery.

Authors:  Olgun Guvench
Journal:  Drug Discov Today       Date:  2016-07-05       Impact factor: 7.851

8.  LpxC Inhibitors: Design, Synthesis, and Biological Evaluation of Oxazolidinones as Gram-negative Antibacterial Agents.

Authors:  Haruaki Kurasaki; Kosuke Tsuda; Mariko Shinoyama; Noriko Takaya; Yuko Yamaguchi; Ryuta Kishii; Kazuhiko Iwase; Naoki Ando; Masahiro Nomura; Yasushi Kohno
Journal:  ACS Med Chem Lett       Date:  2016-04-05       Impact factor: 4.345

9.  Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors.

Authors:  Emilia Caselli; Chiara Romagnoli; Roza Vahabi; Magdalena A Taracila; Robert A Bonomo; Fabio Prati
Journal:  J Med Chem       Date:  2015-07-10       Impact factor: 7.446

10.  Novel GlyT1 inhibitor chemotypes by scaffold hopping. Part 2: development of a [3.3.0]-based series and other piperidine bioisosteres.

Authors:  Douglas J Sheffler; Michael T Nedelcovych; Richard Williams; Stephen C Turner; Brittany B Duerk; Megan R Robbins; Sataya B Jadhav; Colleen M Niswender; Carrie K Jones; P Jeffrey Conn; R Nathan Daniels; Craig W Lindsley
Journal:  Bioorg Med Chem Lett       Date:  2014-01-13       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.